CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 95,380,838
- Share change
- -2,052,931
- Total reported value
- $1,896,646,482
- Put/Call ratio
- 268%
- Price per share
- $19.88
- Number of holders
- 312
- Value change
- -$35,292,712
- Number of buys
- 155
- Number of sells
- 126
Quarterly Holders Quick Answers
What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14888U101:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
18,694,918
|
$289,584,285 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
7.4%
|
9,127,305
|
$141,381,954 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
8,100,355
|
$125,474,498 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
6,033,298
|
$93,455,786 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
3,000,756
|
$46,478,944 | — | 30 Jun 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
2.4%
|
2,967,575
|
$45,967,737 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,698,613
|
$41,809,519 | — | 30 Jun 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
2%
|
2,472,933
|
$38,305,732 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.8%
|
2,175,727
|
$33,702,011 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.8%
|
2,175,641
|
$33,698,409 | — | 30 Jun 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.8%
|
2,162,022
|
$33,489,721 | — | 30 Jun 2024 | |
| Boston Partners |
13F
|
Company |
1.1%
|
1,406,380
|
$21,969,844 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,386,707
|
$21,480,092 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
1,341,564
|
$20,780,826 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,276,304
|
$19,769,949 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
1,232,852
|
$19,098,000 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.99%
|
1,219,537
|
$18,890,629 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.91%
|
1,116,939
|
$17,301,385 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
1,088,131
|
$16,855,149 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
1,012,679
|
$15,686,400 | — | 30 Jun 2024 | |
| Mesirow Institutional Investment Management, Inc. |
13F
|
Company |
0.76%
|
934,234
|
$14,471,285 | — | 30 Jun 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.71%
|
873,900
|
$13,537,000 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.68%
|
839,455
|
$13,003,158 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.68%
|
834,415
|
$12,925,086 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.67%
|
830,556
|
$12,865,312 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
754,725
|
$11,690,690 | — | 30 Jun 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.6%
|
741,675
|
$11,488,546 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.52%
|
640,000
|
$9,913,600 | — | 30 Jun 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.52%
|
639,226
|
$9,901,610 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
625,208
|
$9,684,472 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.5%
|
618,296
|
$9,577,408 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.47%
|
582,921
|
$9,029,446 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.42%
|
518,386
|
$8,029,799 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.41%
|
503,735
|
$7,802,855 | — | 30 Jun 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.41%
|
500,000
|
$7,745,000 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.4%
|
488,386
|
$7,565,099 | — | 30 Jun 2024 | |
| Man Group plc |
13F
|
Company |
0.38%
|
469,844
|
$7,277,884 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
459,765
|
$7,121,760 | — | 30 Jun 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.37%
|
458,400
|
$7,100,616 | — | 30 Jun 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.35%
|
435,631
|
$6,747,924 | — | 30 Jun 2024 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.35%
|
432,210
|
$6,694,934 | — | 30 Jun 2024 | |
| JW Asset Management, LLC |
13F
|
Company |
0.34%
|
413,392
|
$6,403,442 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
374,373
|
$5,799,036 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.26%
|
323,769
|
$5,015,162 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
316,975
|
$4,909,942 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.25%
|
305,444
|
$4,731,327 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.23%
|
288,000
|
$4,461,120 | — | 30 Jun 2024 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.23%
|
282,074
|
$4,369,326 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.22%
|
275,509
|
$4,267,634 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.22%
|
275,000
|
$4,259,750 | — | 30 Jun 2024 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2024
As of 30 Sep 2024,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
312 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,380,838 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Pacer Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, FIRST TRUST ADVISORS LP, and ROYCE & ASSOCIATES LP.
This page lists
314
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
269
Q3 2024 holders
312
Holder diff
43
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.